Literature DB >> 3481311

Acute nongonococcal epididymitis. Aetiological and therapeutic aspects.

W Weidner1, H G Schiefer, C Garbe.   

Abstract

In this study, 20 men suffering from acute nongonococcal epididymitis were treated with ofloxacin 200mg bid given orally for 2 weeks. Patients were re-examined after 2, 6, and 12 weeks. The outcome was assessed both clinically and microbiologically. Two weeks after start of therapy, the causative agent (Chlamydia trachomatis) was still present in only 1 patient, although local painful swelling of the epididymis persisted in 14 men. During the follow-up period, local signs of epididymitis decreased. After 12 weeks, an eradication of the causative micro-organisms was found in 16 of 20 cases. In 4 men, infection by the primary pathogen persisted: Escherichia coli (2); Pseudomonas aeruginosa (1) and C. trachomatis (1). Local pain and swelling was still detected in 6 of 20 men.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3481311     DOI: 10.2165/00003495-198700341-00024

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  16 in total

1.  Experimental production of epididymitis with sterile urine; clinical implications.

Authors:  R S GRAVES; W J ENGEL
Journal:  J Urol       Date:  1950-10       Impact factor: 7.450

2.  [In vitro activity, serum, urine and prostatic adenoma concentrations of ofloxacin in urologic patients with complicated urinary tract infections].

Authors:  K G Naber; D Adam; R Wittenberger; B Bartosik-Wich
Journal:  Infection       Date:  1986       Impact factor: 3.553

3.  Altered bladder function and non-specific epididymitis.

Authors:  S A Koff
Journal:  J Urol       Date:  1976-11       Impact factor: 7.450

4.  Chlamydia trachomatis as a cause of acute "idiopathic" epididymitis.

Authors:  R E Berger; E R Alexander; G D Monda; J Ansell; G McCormick; K K Holmes
Journal:  N Engl J Med       Date:  1978-02-09       Impact factor: 91.245

5.  [Epididymitis. Studies on its etiology and pathogenesis with special reference to Chlamydia trachomatis and Ureaplasma urealyticum].

Authors:  H C Becker; W Weidner; H G Schiefer; H Brunner; W Krause
Journal:  Dtsch Med Wochenschr       Date:  1984-04-13       Impact factor: 0.628

6.  Failure of norfloxacin to eradicate Chlamydia trachomatis in nongonococcal urethritis.

Authors:  W R Bowie; V Willetts; L Sibau
Journal:  Antimicrob Agents Chemother       Date:  1986-10       Impact factor: 5.191

7.  Etiology, manifestations and therapy of acute epididymitis: prospective study of 50 cases.

Authors:  R E Berger; E R Alexander; J P Harnisch; C A Paulsen; G D Monda; J Ansell; K K Holmes
Journal:  J Urol       Date:  1979-06       Impact factor: 7.450

8.  Studies on the role of Ureaplasma urealyticum and Mycoplasma hominis in prostatitis.

Authors:  H Brunner; W Weidner; H G Schiefer
Journal:  J Infect Dis       Date:  1983-05       Impact factor: 5.226

9.  Aetiology of acute epididymitis.

Authors:  J P Harnisch; R E Berger; E R Alexander; G Monda; K K Holmes
Journal:  Lancet       Date:  1977-04-16       Impact factor: 79.321

10.  The clinical use of epididymal aspiration cultures in the management of selected patients with acute epididymitis.

Authors:  R E Berger; K K Holmes; M E Mayo; R Reed
Journal:  J Urol       Date:  1980-07       Impact factor: 7.450

View more
  11 in total

Review 1.  Treatment of genitourinary tract infections with fluoroquinolones: clinical efficacy in genital infections and adverse effects.

Authors:  D C Hooper; J S Wolfson
Journal:  Antimicrob Agents Chemother       Date:  1989-10       Impact factor: 5.191

Review 2.  Ofloxacin. A reappraisal of its antimicrobial activity, pharmacology and therapeutic use.

Authors:  P A Todd; D Faulds
Journal:  Drugs       Date:  1991-11       Impact factor: 9.546

3.  Acute epididymo-orchitis due to Pseudomonas aeruginosa.

Authors:  K A Papadakis; P M Sriram; C M Smythe
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-06       Impact factor: 3.267

4.  Tissue penetration of sparfloxacin in a rat model of experimental Escherichia coli epididymitis.

Authors:  M Ludwig; C A Jantos; S Wolf; M Bergmann; K Failing; H G Schiefer; W Weidner
Journal:  Infection       Date:  1997 May-Jun       Impact factor: 3.553

5.  The implementation of European Association of Urology guidelines in the management of acute epididymo-orchitis.

Authors:  Mary A E Garthwaite; G Johnson; S Lloyd; I Eardley
Journal:  Ann R Coll Surg Engl       Date:  2007-11       Impact factor: 1.891

6.  Comparative efficacies of ofloxacin, cefotaxime, and doxycycline for treatment of experimental epididymitis due to Escherichia coli in rats.

Authors:  E Vieler; C Jantos; H L Schmidts; W Weidner; H G Schiefer
Journal:  Antimicrob Agents Chemother       Date:  1993-04       Impact factor: 5.191

Review 7.  Epididymo-orchitis caused by enteric organisms in men > 35 years old: beyond fluoroquinolones.

Authors:  Laura Ryan; Padraig Daly; Ivor Cullen; Maeve Doyle
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-02-15       Impact factor: 3.267

Review 8.  Ofloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  J P Monk; D M Campoli-Richards
Journal:  Drugs       Date:  1987-04       Impact factor: 9.546

9.  A case of acute epididymo-orchitis due to Pseudomonas aeruginosa presenting as ARDS in an immunocompetent host.

Authors:  Sameer Singhal; D D Wagh; Shivali Kashikar; Yeshwant Lonkar
Journal:  Asian Pac J Trop Biomed       Date:  2011-01

10.  Acute epididymo-orchitis: staging and treatment.

Authors:  Oleg Banyra; Alexander Shulyak
Journal:  Cent European J Urol       Date:  2012-09-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.